Výsledky vyhledávání

Editorial & Opinion

Methodological Concerns Regarding a Retrospective Study With Real-World Data on Paxlovid in Israel.

Autor: Uchikoba S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan., Yamada G; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan., Tsuzuki S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Dec 19; Vol. 75 (12), pp. 2278-2279.

Zobrazit plný text záznamu

Akademický článek

Replacement of SARS-CoV-2 strains with variants carrying N501Y and L452R mutations in Japan: an epidemiological surveillance assessment.

Autor: Kobayashi Y; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan., Arashiro T; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan., Otsuka M; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan., Tsuchihashi Y; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan., Takahashi T; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan., Arima Y; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan., Ko YK; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan., Otani K; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan., Yamauchi M; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan., Kamigaki T; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan., Morita-Ishihara T; Center for Research Planning and Coordination, National Institute of Infectious Diseases, Tokyo, Japan., Takahashi H; Center for Research Planning and Coordination, National Institute of Infectious Diseases, Tokyo, Japan., Uchikoba S; Center for Research Planning and Coordination, National Institute of Infectious Diseases, Tokyo, Japan., Shimatani M; Center for Research Planning and Coordination, National Institute of Infectious Diseases, Tokyo, Japan., Takeshita N; Center for Research Planning and Coordination, National Institute of Infectious Diseases, Tokyo, Japan., Suzuki M; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan., Ohnishi M; Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.

Publikováno v: Western Pacific surveillance and response journal : WPSAR [Western Pac Surveill Response J] 2022 Sep 16; Vol. 13 (3), pp. 1-10. Date of Electronic Publication: 2022 Sep 16 (Print Publication: 2022).

Zobrazit plný text záznamu